Tharimmune (NASDAQ:THAR – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “hold” rating in a report issued on Friday. Get Tharimmune alerts:Read Our Latest Research Report on TharimmuneTharimmune Price PerformanceTHAR stock opened at $2.91 on Friday. Tharimmune (NASDAQ:THAR – Get Free Report) last posted its quarterly earnings results on Thursday, August 14th. Institutional Trading of TharimmuneA hedge fund recently bought a new stake in Tharimmune stock. Further ReadingReceive News & Ratings for Tharimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tharimmune and related companies with MarketBeat.com's FREE daily email newsletter.